Overview
2006Founded1
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2022
55.2%Gross margin5
-40.9%Operating margin5
-51.8%Net margin5
22.0%Revenue growth, 20225
-122.2%Return on equity5
1.04×Debt to equity5
-$33.5MFree cash flow5
Where the money goes
Where each dollar of revenue went, fiscal 2022
- Cost of revenue45¢$34.4M
- Research and development15¢$11.9M
- Other costs33¢$25.3M
- Interest6¢$4.7M
- Income tax1¢$584.0K
Out of $76.9M in revenue.5 The company lost money this year.
Financial statements
No quarterly figures reported.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Revenue | $64.7M6 | $64.3M7 | $60.9M8 | $50.7M9 | $42.0M10 | $63.0M5 | $76.9M5 |
| Cost of revenue | $25.3M6 | $24.6M7 | $27.7M8 | $25.0M9 | $19.8M10 | $28.0M10 | $34.4M5 |
| Gross profit | $39.4M6 | $39.7M7 | $33.2M8 | $25.7M9 | $22.2M10 | $35.0M5 | $42.4M5 |
| Research and development | $7.8M6 | $8.3M7 | $12.2M8 | $10.4M9 | $7.7M10 | $9.5M5 | $11.9M5 |
| Operating income | -$20.8M6 | -$22.4M7 | -$40.1M8 | -$23.5M9 | -$15.8M10 | -$19.2M5 | -$31.4M5 |
| Interest | $18.2M6 | $4.5M7 | $4.1M8 | $4.1M9 | $5.3M10 | $8.3M5 | $4.7M5 |
| Income tax | $387.0K6 | $304.0K7 | $191.0K8 | $275.0K9 | $142.0K10 | $156.0K5 | $584.0K5 |
| Net income | -$41.2M6 | -$27.3M7 | -$45.8M8 | -$27.4M9 | -$22.6M10 | -$24.7M5 | -$39.8M5 |
| Earnings per share | -$0.9910 | -$0.825 | -$0.985 | ||||
| Earnings per share (diluted) | -$0.9910 | -$0.825 | -$0.985 |
No quarterly figures reported.
| Fiscal year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
|---|---|---|---|---|---|---|---|
| Cash | $19.1M6 | $30.5M7 | $24.0M8 | $29.9M9 | $36.2M10 | $90.7M5 | $57.0M5 |
| Current assets | $43.6M6 | $57.6M7 | $48.1M8 | $51.0M9 | $58.5M10 | $114.7M5 | $92.9M5 |
| Total assets | $102.1M6 | $109.1M7 | $74.5M8 | $74.6M9 | $77.4M10 | $131.5M5 | $110.2M5 |
| Current liabilities | $20.3M6 | $25.8M7 | $24.4M8 | $52.8M9 | $11.7M10 | $14.5M5 | $39.5M5 |
| Long-term debt | $39.4M6 | $33.3M7 | $21.2M8 | $09 | $37.2M10 | $33.5M5 | $34.0M5 |
| Total liabilities | $59.7M6 | $59.1M7 | $45.6M8 | $72.5M9 | $70.7M10 | $70.3M5 | $77.6M5 |
| Shareholders’ equity | $42.4M7 | $49.9M8 | $28.8M9 | $2.1M10 | $6.8M5 | $61.2M5 | $32.6M5 |
| Shares outstanding | 10.7M shares6 | 17.3M shares7 | 21.9M shares8 | 21.0M shares9 | 25.8M shares10 | 39.5M shares5 | 42.0M shares5 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Compare Apollo Endosurgery (United States) with another company
Former names
Timeline
- 2006Founded Founded1
Recent filings
- Apr 4, 20238-K
- Apr 4, 20234
- Apr 4, 20234
- Apr 4, 20234
- Apr 4, 20234
- Apr 4, 20234
- Apr 4, 20234
- Apr 4, 20234
- Apr 4, 20234
- Apr 4, 20234
- Apr 4, 20234
- Apr 4, 20234
- Apr 4, 20234
- Apr 4, 20234
- Mar 30, 202310-K
Every filing from the last three years, summarized. The full record is on SEC EDGAR.2
Links
- Websiteapolloendo.com1
- WikidataQ50039483
- SEC EDGARCIK 1251769
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3Company websiteApollo Endosurgery (United States) logo
- 4
- 5
- 6
- 7
- 8
- 9
- 10